We use GFP as a fate map marker in chimeric mice. We are working on a protocol for a skin digest to analyze the turnover of leukocytes in the skin. The protocol works beautifully on a non-GFP animal, but when GFP is involved, only about 70- 80% of the CD45+ population is GFP+ And the fluorescence is extremely high making compensation extremely difficult. Does anyone have experience in using GFP in the skin of mice. Is this varying expression expected?